PLUS THERAPEUTICS, Inc. Common Stock

PSTV XNAS • SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

26M

Short interest (Jul 15)

10.3%

Net Short (Jul 27 ): -0.1%

Borrow Fee

36.28%

↓ 46.5%

Available Shares

200K

↓ 10.5%

Price Chart

Company Overview

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, commercializing and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

Company Info

Exchange: NASDAQ

Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

CIK: 0001095981

Asset Type: CS

Market Data

Market Cap: $26,365,325

Employees: 28

Status: Active

Short Interest

Current Borrow Fee 36.28%

Range: 31.29% - 36.28%

Available Shares 200K

Range: 65K - 150K

Recent Changes

Fee Change: ↓ 9.4%

Available Change: ↑ 55.2%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime